Acute Coronary Syndromes. From the Emergency Department to the Cardiac Care Unit

Cardiology Clinics

Volumn 30, Issue 4, 2012, Pages 617-627

  Mistry, Neville F ^a   Vesely, Mark R ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Acute coronary syndrome; Rapid assessment; Reperfusion therapy; Risk stratification

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; ENOXAPARIN; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; FONDAPARINUX; GLYCERYL TRINITRATE; HEPARIN; HIRULOG; LOW MOLECULAR WEIGHT HEPARIN; METOPROLOL; NITRATE; PLACEBO; PRASUGREL; THIENOPYRIDINE DERIVATIVE; TICAGRELOR; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ALLERGIC REACTION; BLEEDING; CORONARY ARTERY THROMBOSIS; CORONARY CARE UNIT; EMERGENCY CARE; EMERGENCY WARD; HEADACHE; HEPARIN INDUCED THROMBOCYTOPENIA; HOSPITAL CARE; HUMAN; HYPOTENSION; LOADING DRUG DOSE; MORBIDITY; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; REPEATED DRUG DOSE; REVIEW; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNITED STATES; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; ADRENERGIC BETA-ANTAGONISTS; ANTICOAGULANTS; CREATINE KINASE, MB FORM; ELECTROCARDIOGRAPHY; EMERGENCY MEDICAL SERVICES; HOSPITAL UNITS; HUMANS; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; THROMBOLYTIC THERAPY; TROPONIN;

EID: 84868132617     PISSN: 07338651     EISSN: 15582264     Source Type: Journal    
DOI: 10.1016/j.ccl.2012.07.010     Document Type: Review

References (56)

1. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011, 123:e18-e209.
2. Fox K.A., Steg P.G., Eaglke K.A., et al. GRACE investigators. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 2007, 297:1892-1900.
3. Peterson E.D., Roe M.T., Lytle B.L., et al. The association between care and outcomes in patients with acute coronary syndromes: national results from CRUSADE. J Am Coll Cardiol 2004, 43:406A.
4. Peterson E.D., Parsons L.S., Pollack C.V., et al. Variations in AMI care quality across 1085 hospitals and its association with hospital mortality rates. Circulation 2002, 106:II-722.
5. Goff D.C., Feldman H.A., McGovern P.G., et al. Prehospital delay in patients hospitalized with heart attack symptoms in the United States: the REACT trial. Rapid Early Action for Coronary Treatment (REACT) Study Group. Am Heart J 1999, 138:1046-1057.
6. Canto J.G., Shlipak M.G., Rogers W.J. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA 2000, 283:3223-3229.
7. Patel M., Dehmer G.J., Hirshfeld J.W., et al. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate use criteria for coronary revascularization focused update. J Am Coll Cardiol 2012, 59(9):857-881.
8. Vesley M.R., Keleman M.D. Cardiac risk assessment: matching intensity of therapy to risk. Cardiol Clin 2006, 24:67-78.
9. Sabatine M.S., Antman E.M. The thrombolysis in myocardial infarction risk score in unstable angina/non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 2003, 41:89S.
10. Antman E.M., Cohen M., Bernink P.J., et al. The TIMI risk score for unstable angina/non-ST segment elevation: a method for prognostication and therapeutic decision making. JAMA 2000, 284:835-842.
11. Morrow D.A., Antman E.M., Snapinn S.M., et al. An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS. Eur Heart J 2002, 23:223-229.
12. Cohen M., Demers C., Gurfinkel E.P., et al. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med 1997, 337:447.
13. Cannon C.P., Weintraub W.S., Demopoulos L.A., et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001, 344:1879.
14. Boersma E., Pieper K.S., Steyerberg E.W., et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation 2000, 101:2557.
15. Granger C.B., Goldberg R.J., Dabbous O., et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003, 163:2345.
16. Jayes R.L.J., Beshansky J.R., D'agostino R.B., et al. Do patients' coronary risk factor reports predict acute cardiac ischemia in the emergency department? A multicenter study. J Clin Epidemiol 1992, 45:621-626.
17. Jayes R., Larsen G., Beshansky J., et al. Physician electrocardiogram reading in the emergency department: accuracy and effect on triage decisions: findings from a multicenter study. J Gen Intern Med 1992, 7:387-392.
18. Pope J., Ruthazer R., Beshansky J., et al. Clinical features of emergency department patients presenting with symptoms of acute cardiac ischemia: a multicenter study. J Thromb Thrombolysis 1998, 6:63-74.
19. Henrikson C.A., Howel E.E., Bush D.E., et al. Chest pain relief by nitroglycerin does not predict active coronary artery disease. Ann Intern Med 2003, 139:979-986.
20. Swap C.J., Nagurney J.T. Value and limitations of chest pain history in the evaluation of patients with suspected acute coronary syndromes. JAMA 2005, 294:2623-2629.
21. Lee T., Cook E., Weisberg M., et al. Acute chest pain in the emergency room: identification and examination of low-risk patients. Arch Intern Med 1985, 145:65-69.
22. Holmes D.R., Berger P.B., Hochman J.S., et al. Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevation. Circulation 1999, 100:2067-2073.
23. Anderson J.L., Adams C.D., Antman E.M., et al. ACC/AHA 2007 Guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction-executive summary. J Am Coll Cardiol 2007, 50:652-726.
24. Selker H.P., Zalenski R.J., Antman E.M., et al. An evaluation of technologies for identifying acute cardiac ischemia in the emergency department. Ann Emerg Med 1997, 29:1-87.
25. Matetzky S., Freimark D., Feinberg M.S., et al. Acute myocardial infarction with isolated ST-segment elevation in posterior chest leads V7-V9: " hidden" ST-segment elevation revealing acute posterior infarction. J Am Coll Cardiol 1999, 34:748-753.
26. Matetzky S., Freimark D., Chouraqui P., et al. Significance of ST segment elevations in posterior chest leads V7 to V9 in patients with acute inferior myocardial infarction: application for thrombolytic therapy. J Am Coll Cardiol 1998, 31:506-511.
27. Thygesen K., Alpert J.S., White H.D., et al. Universal definition of myocardial infarction. Circulation 2007, 116:2634-2653.
28. Antman E.M., Tanasijevic M.J., Thompson B., et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996, 335:1342-1349.
29. Keeley E.C., Boura J.A., Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003, 361(9351):13.
30. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2004, 110(9):e82.
31. Antman E.M., Hand M., Armstrong P.W., et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2008, 51(2):210-247.
32. Sabatine M.S., Cannon C.P., Gibson C.M., et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 2005, 352:1178-1189.
33. Theroux P., Ouimet H., McCans J., et al. Aspirin, sulfinpyrazone or both in unstable angina: results of a Canadian multicenter trial. N Engl J Med 1985, 313:1369-1375.
34. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002, 324(7330):141. Antithrombotic Trialists' Collaboration.
35. Chen Z.M., Jiang L.X., Xie J.X., et al. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomized placebo-controlled trial. Lancet 2005, 366(9497):1607-1621.
36. Yusuf S., Zhao F., Mehta S.R., et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001, 345(7):494.
37. Mehta S.R., Yusuf S., Peters R.J., et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001, 358:527-533.
38. Gurbel P.A., Mahla E., Antonino M.J., et al. Response variability and the role of platelet function testing. J Invasive Cardiol 2009, 21(4):172.
39. Cairns J.A., Eikelbloom J. Clopidogrel resistance: more grist for the mill. J Am Coll Cardiol 2008, 51(20):1935.
40. Serebruany V.L., Steinhubl S.R., Berger P.B., et al. Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol 2006, 48:2584-2591.
41. Matetzky S., Shenkman B., Guetta V., et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 2004, 109:3171-3175.
42. Wiviott S.D., Braunwald E., McCabe C.H., et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007, 357:2001-2015.
43. Wright R.S., Anderson J.L., Adams C.D. 2011 ACCF/AHA focused update of the guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction. J Am Coll Cardiol 2011, 57:1920-1959.
44. Wallentin L., Becker R.C., Budaj A., et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009, 361:1045-1057.
45. Theroux P., Ouimet H., McCans J., et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 1988, 319(17):1005.
46. Theroux P., Waters D., Qiu S., et al. Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina. Circulation 1993, 88(5 Part 1):2045.
47. Ferguson J.J., Califf R.M., Antman E.M., et al. Enoxaparin vs. unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNGERGY randomized trial. JAMA 2004, 292(1):45.
48. Stone G.W., McLaurin B.T., Cox D.A., et al. Bivalirudin for patients with acute coronary syndromes. N Engl J Med 2006, 355(21):2203.
49. Stone G.W., White H.D., Ohman E.M., et al. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial. Lancet 2007, 369(9565):907.
50. Stone G.W., Witzenbichler B., Guagliumi G., et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008, 358(21):2218.
51. Lopes R.D., Alexander K.P., Manoukian S.V., et al. Advanced age, antithrombotic strategy, and bleeding in non-ST-segment elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial. J Am Coll Cardiol 2009, 53(12):1021.
52. Kastrati A., Neumann F.J., Mehilli J., et al. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention. N Engl J Med 2008, 359(7):688.
53. The MIAMI Trial Research Group. Metoprolol in acute myocardial infarction. Am J Cardiol 1985, 56(14):10G-14G.
54. Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet 1986, 2(8498):57-66.
55. Chen Z.M., Pan H.C., Chen Y.P., et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomized placebo-controlled trial. Lancet 2005, 366(9497):1622.
56. Giugliano R.P., White J.A., Bode C., et al. Early versus delayed, provision eptifibatide in acute coronary syndromes. NEJM 2009, 3650:2176-2190.